Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Mar. 14 | Cullinan Oncology Finance Chief Jeffrey Trigilio to Leave | MT |
Mar. 01 | Cullinan Oncology Secures FDA Approval for CLN-619's Investigational New Drug Application in Multiple Myeloma | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
-12.89% | 3.24B | |
+0.97% | 1.53B | |
+3.91% | 980M | |
+82.85% | 881M | |
+1.45% | 701M | |
-16.04% | 627M | |
+18.74% | 606M | |
-.--% | 153M | |
+31.36% | 107M |
- Stock
- Equities
- Stock Consolidated Gems, Inc. - OTC Markets
- News Consolidated Gems, Inc.
- Cullinan Oncology Posts Wider Q3 Loss; Cash, Equivalents Decline